DayStar Announces Results of Annual Shareholders' Meeting

HALFMOON, N.Y., Dec. 13 /PRNewswire-FirstCall/ -- DayStar 

Technologies, Inc. (Nasdaq: DSTI) announced today the outcome 

of the Company's shareholder meeting which was held in Santa 

Clara, CA on December 11, 2007.

A total of 21,936,231 shares, or approximately 68% of the total 

Number of shares entitled to vote at the meeting, were represented, 

and the Company's shareholders elected to have the following 

persons continue to serve as members of the Board of Directors: 

Dr. Randolph A. Graves, Jr., Dr. Stephan J. DeLuca, Dr. Robert G. 

Aldrich, Kevin S. Flannery, Richard Nevins, Scott M. Schecter and Kelly 

A. Waters. In addition, the Board of Directors reelected Dr. Randolph 

A. Graves, Jr. as Chairman.

About DayStar Technologies, Inc.

DayStar Technologies, Inc. is engaged in the development, manufacturing, and marketing of photovoltaic products based upon CIGS thin film semiconductor technology.

This news release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including risks that we will not be able to manufacture our products or that they will not perform as expected, and other risks identified in our Registration Statement on Form SB-2 and other filings with the SEC. You should consider these factors in evaluating the forward- looking statements included herein, and not place undue reliance on such statements. The forward-looking statements are made as of the date hereof and DayStar Technologies, Inc. undertakes no obligation to update such statements.

 

For more information, contact:

 

Kellie Caughorn

InfusionCapital

407-566-1051

kcaughorn@InfusionCapital.com

www.infusioncapital.com